Past ARDS Speakers
“The list is huge. Many of us are very cognizant of the fact that we truly do stand on the shoulders of giants. In retina, many of the giants came regularly to that meeting. I remember very vividly being there with everyone from Tom Aaberg, Sr. to Steve Charles to Don Gass, many of the real luminaries in our field… Here was an opportunity to not only listen, but to stand up in front of your peers and probe into important clinical questions in a forum that not only permitted it, but encouraged it.”
David Parke, II
Records per page:
2014 42nd Annual Meeting
Thomas R. Friberg, MDThe Peripheral Retina and its Implications for Age-Related Macular Degeneration
Julia A. Haller, MDNothing in Vein: The Evolution of Management of Retinal Vein Occlusions
Szilárd Kiss, MDLatest Observations on Wide-Field Imaging of Retinal Diseases
David W. Parke, II, MDThe Law of Unintended Consequences in Health Care Reform
Carl D. Regillo, MDAnti-VEGF Maintenance Therapy for Neovascular AMD
Srinivas R. Sadda, MDFuture Optical Coherence Tomography (OCT) Imaging
Srinivas R. Sadda, MDLocal Risk Factors for Development of Geographic Atrophy: New Insights into AMD Pathogenesis
Ramin Tadayoni, MD, PhDHigh Myopia: What We Peel and What We Should Peel
Ramin Tadayoni, MD, PhDIs Fluorescein Angiography Still the Sole Gold Standard for the Diagnosis of Neovascular AMD?
2013 41st Annual Meeting
David M. Brown, MDCan Widefield FFA-guided PRP Decrease Treatment Burden in Vascular Diseases?
David M. Brown, MDIs There a Correlation Between Changes in OCT and Visual Acuity in the Management of Wet ARMD?
Philip J. Ferrone, MDAdvanced Imaging and Intravitreal Therapy in the Pediatric Patient
Philip J. Ferrone, MDPediatric Retina Surgery — Update and Clinical Pearls
Tarek S. Hassan, MDThe Continued Evolution of Vitrectomy: How it Impacts Current Clinical Care
Tarek S. Hassan, MDThe Current Management of Refractory Diabetic Macular Edema
Daniel F. Martin, MDLessons Learned in the Management of Posterior Uveitis
Daniel F. Martin, MDTop 10 Findings from the Comparison of AMD Treatments Trials (CATT)
Joan W. Miller, MDCurrent and Future Therapies of AMD
Joan W. Miller, MDNeuroprotection for Retinal Disorders
Virgilio Morales-Canton, MDEndophthalmitis from the Retina Surgeon’s Perspective — Complications of Intravitreal Injection Therapy and Pars Plana Vitrectomy
Virgilio Morales-Canton, MDVitrectomy Management of Complications of Diabetic Retinopathy
Timothy G. Murray, MD, MBAUpdate on Management for Complex Pediatric Retinoblastoma and Melanoma: Impact of Imaging, Anti-VEGF, and Metabolism on Tumor Control and Functional Outcome
David W. Parke, II, MDWhat’s the Election’s Healthcare Impact? What Happens Now?
John T. Thompson, MDAdvances in the Treatment of Lamellar and Full-Thickness Macular Holes
John T. Thompson, MDDoes Vitrectomy Increase the Risk for Development of Glaucoma?
PREV 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 NEXT